Hookipa Net Interest Income from 2010 to 2026
| HOOK Stock | USD 1.00 0.01 1.01% |
Net Interest Income | First Reported 2019-03-31 | Previous Quarter 236 K | Current Value 254 K | Quarterly Volatility 757.8 K |
Check Hookipa Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hookipa Pharma's main balance sheet or income statement drivers, such as Net Interest Income of 4.5 M, Interest Income of 4.5 M or Depreciation And Amortization of 2.9 M, as well as many indicators such as Price To Sales Ratio of 0.63, Dividend Yield of 0.0 or PTB Ratio of 0.64. Hookipa financial statements analysis is a perfect complement when working with Hookipa Pharma Valuation or Volatility modules.
Hookipa | Net Interest Income | Build AI portfolio with Hookipa Stock |
Historical Net Interest Income data for Hookipa Pharma serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Hookipa Pharma represents a compelling investment opportunity.
Latest Hookipa Pharma's Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Hookipa Pharma over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Hookipa Pharma's Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hookipa Pharma's overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Hookipa Net Interest Income Regression Statistics
| Arithmetic Mean | 692,788 | |
| Coefficient Of Variation | 302.87 | |
| Mean Deviation | 1,706,314 | |
| Median | (606,000) | |
| Standard Deviation | 2,098,223 | |
| Sample Variance | 4.4T | |
| Range | 5.5M | |
| R-Value | 0.79 | |
| Mean Square Error | 1.8T | |
| R-Squared | 0.62 | |
| Significance | 0.0002 | |
| Slope | 327,337 | |
| Total Sum of Squares | 70.4T |
Hookipa Net Interest Income History
About Hookipa Pharma Financial Statements
Hookipa Pharma investors utilize fundamental indicators, such as Net Interest Income, to predict how Hookipa Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 4.3 M | 4.5 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Hookipa Pharma Correlation against competitors. For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. Market participants price Hookipa higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Hookipa Pharma assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (4.82) | Revenue Per Share | Quarterly Revenue Growth (0.94) | Return On Assets | Return On Equity |
Investors evaluate Hookipa Pharma using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Hookipa Pharma's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Hookipa Pharma's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Hookipa Pharma's market price signifies the transaction level at which participants voluntarily complete trades.